Kreos Capital

BioLineRx Ltd. is a clinical-stage biopharmaceutical development company based in Modi’in, Israel, specializing in oncology. The company's development pipeline includes several therapeutic candidates, such as BL-8040, a peptide designed for treating solid tumors, hematological malignancies, and facilitating stem cell mobilization. Another key candidate is AGI-134, an immuno-oncology agent aimed at solid tumors. Additionally, BioLineRx has developed BL-5010, a proprietary pen-like applicator intended for the non-surgical removal of skin lesions. The company has established collaborations with prominent organizations, including MSD for cancer immunotherapy, MD Anderson Cancer Center to explore the combination of BL-8040 with KEYTRUDA in pancreatic cancer, and Genentech Inc. for studies involving BL-8040 and TECENTRIQ in solid tumors. Founded in 2003, BioLineRx is focused on addressing unmet medical needs and improving existing therapies in the pharmaceutical market.

Abivax is a clinical-stage biotechnology company based in France that develops therapeutics aimed at harnessing the body's natural immune response to treat autoimmune diseases, viral infections, and cancer. The company is currently evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Abivax focuses on addressing significant unmet medical needs in chronic inflammatory diseases, particularly inflammatory bowel diseases, which include ulcerative colitis and Crohn's disease. Through its innovative drug development platforms, Abivax aims to provide novel and effective treatment options for patients suffering from these conditions.

Crescendo Biologics Limited is a Cambridge-based company focused on developing innovative therapies for oncology and dermatology, particularly through small molecules and monoclonal antibodies. The company specializes in multi-specific immune-oncology modulators and Humabody Drug Conjugates, leveraging a proprietary transgenic mouse platform that facilitates the in vivo maturation of human VH domains. This technology allows Crescendo to optimize the affinity and biophysical properties of its Humabodies, which are small antibody fragments retaining essential binding capabilities. By addressing challenges in generating high-affinity, soluble human VH antibody fragments, Crescendo aims to develop potent, multi-functional therapeutics. The company engages in both in-house product development and partnerships with other organizations to expand its impact in the field of antibody therapeutics. Established in 2007, Crescendo Biologics was originally named Translocus Limited before rebranding in 2009.

Sdui GmbH, founded in 2017 and based in Koblenz, Germany, is a rapidly growing education technology company that specializes in enhancing communication within educational institutions. The company offers a comprehensive digital platform designed to connect teachers, students, parents, and educational administrators through various intelligent features. Its solutions include tools for managing class schedules, parent communications, online class registrations, and room bookings, thereby streamlining administrative tasks and allowing educators to focus on delivering quality education. Sdui is committed to compliance with GDPR regulations, ensuring data protection while providing functionalities such as chat, translation, cloud services, and AI lesson planning tailored to the needs of schools and preschools. With its recent expansion through the acquisition of FoxEducation, Sdui now serves 22,000 educational institutions across over 70 countries, employing approximately 230 people.

Finbourne Technology Limited, founded in December 2016 and headquartered in London, United Kingdom, specializes in developing LUSID, an investment management platform aimed at transforming and simplifying investment data handling. The platform serves as a comprehensive investment data store that secures a complete history of all transactions and adjustments, thereby enhancing transparency and reducing costs associated with investing. With a team that has expanded from seven founders to over 130 in just a few years, Finbourne offers software-as-a-service solutions that provide agility and control in data management. LUSID is designed to integrate with existing operational systems through open APIs, supporting various investment workflows, including investment book of record, accounting, and risk assessments. Additionally, Luminesce, a data virtualization engine, facilitates real-time access to a broad spectrum of data, enabling deeper insights and analytics. Together, these offerings cater to a range of clients, from startup managers to large global investment institutions.

Ukio operates an apartment rental platform that focuses on providing well-furnished, turnkey apartments for monthly stays. By offering a network of design-forward accommodations, Ukio aims to simplify the rental process, eliminating the challenges associated with traditional housing. Clients benefit from furnished and serviced apartments that allow for flexible living arrangements without the burden of long-term contracts, moving logistics, or additional costs such as security deposits and broker fees. This model combines the comforts of home with the conveniences typically associated with hotel stays, catering to individuals seeking a more adaptable housing solution.

Beekeeper is a mobile communication platform designed specifically for non-desk employees, facilitating real-time messaging and targeted communication across various shifts, locations, and languages. By integrating operational systems and communication channels into a single secure hub, Beekeeper enhances employee engagement and retention while automating processes and minimizing reliance on paper. The platform enables frontline workers to access essential resources such as schedules and paystubs, share files, and assign tasks through group chats or predefined streams. With accessibility from both desktop and mobile devices, Beekeeper empowers organizations to improve productivity and streamline workplace operations effectively.

Ibex Medical Analytics Ltd, based in Tel Aviv, Israel, specializes in developing AI-based diagnostic systems for cancer pathology. The company's flagship product, the Ibex Second Read system, works alongside human pathologists to analyze cases, identifying discrepancies in diagnoses. This innovative technology harnesses artificial intelligence, data science, and machine learning to analyze digitized glass slides and electronic medical records, revealing critical patterns that enhance clinical decision-making. By streamlining pathology workflows, Ibex aims to provide rapid, objective, and accurate diagnoses, ultimately improving patient outcomes and quality of life. The company comprises a multidisciplinary team of entrepreneurs, data scientists, software engineers, and medical experts dedicated to advancing cancer care through AI applications in diagnostics.

Variantyx Inc. is a biotechnology company based in Framingham, Massachusetts, founded in 2014. The company specializes in diagnostic testing for rare disorders through its whole genome sequencing (WGS) platform, known as Genomic Unity®. This innovative test analyzes a single patient sample to identify and report all major variant types, including small sequence changes, structural variants, mitochondrial variants, and short tandem repeat expansions. By providing a comprehensive approach to genetic testing, Variantyx eliminates the need for traditional, step-wise genetic testing methods. The platform is designed to generate clinical reports that help hospitals and commercial laboratories accurately understand a patient's genetic makeup, leading to improved diagnosis and optimized treatment recommendations for inherited disorders.

Combining human expertise with a web-based platform, DataGuard is the end-to-end solution for managing your privacy and information security with total peace of mind. Over 2,000 customers trust us to comply with regulations like the GDPR, attain and retain certifications such as ISO 27001, or manage consents and preferences with ease. With over 150 employees in Munich, Berlin and London, we help you to efficiently integrate privacy and information security into your processes. Together we form a true partnership, driving compliance and generating value through trust and transparency.

BioLineRx Ltd. is a clinical-stage biopharmaceutical development company based in Modi’in, Israel, specializing in oncology. The company's development pipeline includes several therapeutic candidates, such as BL-8040, a peptide designed for treating solid tumors, hematological malignancies, and facilitating stem cell mobilization. Another key candidate is AGI-134, an immuno-oncology agent aimed at solid tumors. Additionally, BioLineRx has developed BL-5010, a proprietary pen-like applicator intended for the non-surgical removal of skin lesions. The company has established collaborations with prominent organizations, including MSD for cancer immunotherapy, MD Anderson Cancer Center to explore the combination of BL-8040 with KEYTRUDA in pancreatic cancer, and Genentech Inc. for studies involving BL-8040 and TECENTRIQ in solid tumors. Founded in 2003, BioLineRx is focused on addressing unmet medical needs and improving existing therapies in the pharmaceutical market.

Latana Brand Tracking is a provider of cloud-based data technology that revolutionizes the brand tracking process. By utilizing proprietary mobile methodologies, the company focuses on collecting high-quality attitudinal data through millions of micro surveys distributed globally. This system allows for the real-time analysis of consumer attitudes, public opinion, and market trends, thereby offering valuable insights to research agencies, brands, consultancies, public institutions, and academia. Latana aims to eliminate guesswork in brand and marketing strategies, providing reliable data that empowers organizations to make informed decisions and optimize their campaigns, similar to the role Google Analytics plays in other marketing channels.

Gravitee.io develops an open-source API management platform that assists organizations in securing, publishing, and analyzing their APIs. The platform provides a user-friendly environment that consolidates various API management functions, including analytics dashboards, a developer portal, identity and access management, and security access tools. These features enable businesses to design, manage, deploy, and monitor their APIs in a secure and governed manner. Gravitee's solution is designed to be cost-effective, allowing organizations to access a comprehensive and secure interface for their API needs without incurring significant expenses.

Latana Brand Tracking is a provider of cloud-based data technology that revolutionizes the brand tracking process. By utilizing proprietary mobile methodologies, the company focuses on collecting high-quality attitudinal data through millions of micro surveys distributed globally. This system allows for the real-time analysis of consumer attitudes, public opinion, and market trends, thereby offering valuable insights to research agencies, brands, consultancies, public institutions, and academia. Latana aims to eliminate guesswork in brand and marketing strategies, providing reliable data that empowers organizations to make informed decisions and optimize their campaigns, similar to the role Google Analytics plays in other marketing channels.

Sequana Medical AG is a Swiss medical device company that specializes in developing implantable pump systems to manage fluid balance in the body. Its flagship product, the alfapump, is designed to continuously remove ascites, a condition characterized by fluid accumulation in the abdominal cavity, commonly seen in patients with advanced liver disease, certain cancers, or congestive heart failure. The alfapump is notable for being the first automated system that facilitates the natural expulsion of excess fluid through urination. In addition to treating ascites, the company's pump technology has potential applications in managing pleural effusions and fluid overload in patients with end-stage renal disease and heart failure. Founded in 2002 and headquartered in Zurich, Switzerland, Sequana Medical has expanded its reach to various markets, with a significant portion of its revenue generated in Germany.

Treasury Intelligence Solutions GmbH is a software provider based in Walldorf, Germany, specializing in smart payments solutions for medium-sized and large enterprises. Founded in 2010, the company offers a Software-as-a-Service platform that enhances the management of corporate payments, liquidity, and bank relationships on a global scale. Its flagship product, the Bank Transaction Manager, is a web-based, multi-bank-capable platform that integrates with SAP to streamline payment processes, ensuring efficiency, transparency, and security. Additional offerings include the Bank Account Manager, which serves as a central repository for managing global bank accounts, and the Bank Fee Manager, designed to control bank charges and analyze banking relationships. Treasury Intelligence Solutions has established a strategic alliance with Cashforce and is recognized for empowering CFOs and finance teams to optimize cash flow and payment functions through enhanced connectivity with banking systems and improved compliance measures. The company supports a vast network of banking options and manages significant daily cash volumes, fostering digital transformation across various industries.

Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for everyone to make faster, more informed decisions. It provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Decision Intelligence Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Learn more www.pyramidanalytics.com

PolyPid Ltd. is a clinical-stage biopharmaceutical company based in Petach Tikva, Israel, specializing in the development of innovative drug delivery systems using its proprietary Polymer-Lipid Encapsulation Matrix (PLEX) technology. Founded in 2008, PolyPid focuses on creating products that enable controlled and prolonged release of active pharmaceutical ingredients (APIs) for various healthcare applications. The company's flagship products include D-PLEX, designed to prevent and treat surgical site infections, and BONYPID, which addresses bone-related infections through antibiotic-eluting granules and substitutes. PolyPid's technology allows for localized administration of drugs with pre-determined release rates, optimizing treatment regimens across different therapeutic areas. Additionally, the company is exploring other product candidates, including OncoPLEX for potential intra-tumoral therapy.

VectivBio AG is a clinical-stage biotechnology company based in Basel, Switzerland, founded in 2019 as a spinout from Therachon. The company specializes in the discovery, development, and commercialization of innovative treatments for severe rare diseases, particularly those with significant unmet medical needs. Its lead product candidate, Apraglutide, is a synthetic GLP-2 analog designed to enhance the intestine’s ability to absorb fluids and nutrients, thereby reducing the reliance on parenteral support in patients with short bowel syndrome. VectivBio is dedicated to developing best-in-disease therapies that aim to meaningfully improve the lives of patients and their families, providing more than just incremental advancements over existing standard-of-care options.

Moove is a mobility fintech company focused on providing revenue-based vehicle financing to mobility entrepreneurs across Africa. By leveraging embedded alternative credit-scoring technology, Moove integrates its services within ride-hailing, logistics, and last-mile delivery platforms. This innovative approach allows the company to assess the performance and revenue of mobility entrepreneurs, enabling it to underwrite loans for individuals who have been historically excluded from traditional financial services. Through its unique model, Moove aims to democratize vehicle ownership and enhance access to financial resources for a growing number of mobility operators in the region.

Moove is a mobility fintech company focused on providing revenue-based vehicle financing to mobility entrepreneurs across Africa. By leveraging embedded alternative credit-scoring technology, Moove integrates its services within ride-hailing, logistics, and last-mile delivery platforms. This innovative approach allows the company to assess the performance and revenue of mobility entrepreneurs, enabling it to underwrite loans for individuals who have been historically excluded from traditional financial services. Through its unique model, Moove aims to democratize vehicle ownership and enhance access to financial resources for a growing number of mobility operators in the region.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Numan is a digital platform focused on men's health, providing online access to medical professionals, prescription medications, at-home blood testing, and holistic health advice. The company addresses various health issues, including erectile dysfunction, premature ejaculation, hair loss, and nutritional deficiencies, through its integrated-care platform. By promoting accessible medical remedies, Numan empowers men to take control of their health and wellbeing, while also tackling the gender gap in healthcare-seeking behaviors. Through a combination of prescription medication, doctor consultations, and diagnostics, Numan offers a direct-to-consumer service that encourages men to confront health issues that impact their self-esteem and lifestyle choices.

Numa Group is a Berlin-based company recognized as the leading European operator of a fully digitized hospitality platform. It provides modern travelers with innovative accommodation options that serve as an alternative to boutique hotels and managed short-stay apartments. Numa's offerings include features such as electronic check-in, kitchen facilities, workstations, professional housekeeping, and locally curated recommendations, aiming to deliver an authentic experience for guests. The company employs proprietary technology to automate many operational processes, enhancing cost efficiency and revenue for property owners and investors. Numa currently manages over 8,000 units across major European cities, including Berlin, London, Paris, and Rome, positioning itself as a reliable partner in the hospitality sector.

FintechOS is a leader in fintech enablement, dedicated to making financial technology innovation accessible for all companies. Its cloud-based platform simplifies and accelerates the development, servicing, and expansion of financial products and services, enabling businesses to achieve value significantly faster than traditional methods—often within just 12 weeks. By liberating data from core systems, FintechOS allows for the creation of personalized financial solutions and customer experiences at scale. The platform is versatile, integrating seamlessly with existing technologies and connecting to a variety of ecosystems, both financial and non-financial. FintechOS serves a diverse clientele, including major firms like Groupe Société Générale and Admiral Group, as well as innovative companies such as Vibrant and eMag. The company collaborates with a range of partners, from niche consulting agencies to global consulting firms, enhancing its ability to provide tailored solutions that increase return on investment and reduce time-to-market.

Voi, Inc. is a behavioral healthcare technology company that focuses on using artificial intelligence to address suicide prevention and other behavioral health challenges. The company offers two primary products: Voi Detect, an AI-driven solution designed to identify near-term suicide risk through a digital interface, and Voi Reach, a mobile application that supports at-risk individuals by connecting them with a network of family, friends, and therapists. These solutions cater to service members, patients, students, and veterans, aiming to assist those at risk and their support systems. Founded in 2013 and initially known as First Opinion, Inc., Voi is headquartered in San Francisco, California.

HungryPanda Limited is a food delivery platform that specializes in providing authentic Chinese cuisine and groceries, primarily serving Chinese communities living abroad. Founded in 2016 and based in Nottingham, United Kingdom, the company operates an online B2C platform accessible through web and mobile applications. HungryPanda lists a variety of Chinese restaurants and supermarkets, allowing customers to place orders and make payments conveniently. The platform is designed with user preferences in mind, ensuring a seamless experience. With a presence in over 60 major cities across countries such as the UK, France, Australia, New Zealand, the US, and Canada, HungryPanda has established itself as a global leader in its niche. The company's success is attributed to its strong operational efficiency, specialized focus on the needs of overseas Chinese, and an effective distribution system that enhances its food and retail ecosystem.

Biophytis SA is a clinical-stage biotechnology company based in Paris, France, dedicated to developing therapeutics that aim to slow degenerative processes linked to aging and enhance functional outcomes for patients with age-related diseases. The company focuses on activating key biological resilience pathways to mitigate the effects of various biological and environmental stresses that contribute to these conditions. Biophytis has two primary drug candidates: Sarconeos (BIO101), an orally administered small molecule being developed for neuromuscular diseases such as sarcopenia and Duchenne muscular dystrophy, and Macuneos (BIO201), also an orally administered small molecule targeting retinal diseases like dry age-related macular degeneration and Stargardt disease. The company has established a collaboration agreement with AFM-Telethon for the development of Sarconeos. Founded in 2006, Biophytis aims to become a leader in aging science by providing innovative therapies to address the needs of patients with limited treatment options.

Recharge is a B2C prepaid payments platform operating multiple digital storefronts including Recharge.com and Startselect.com. With its mission to 'Make Prepaid Easy,' the company distributes over 16,000 different types of digital vouchers and prepaid products, for large prepaid categories such as e-gift, shopping, and gaming cards, prepaid money cards, and international mobile and cross-border top ups. Through providing consumers with simple access to these Prepaid Payment Products they are driving a new era of accessibility to financial empowerment, giving consumers greater spending control and flexibility on their terms. Founded in 2010, today they operate in over 180 markets whilst headquartered in Amsterdam. The company is backed by Prime Ventures, Smartfin, Committed Capital and BlackRock raising ~$75M in Series A & B rounds to date.

EGYM is a global fitness technology company that specializes in providing intelligent workout solutions for fitness and health facilities. The company offers a comprehensive platform that integrates connected gym equipment and software, enabling operators to enhance the workout experience for their members. EGYM's offerings include a B2B corporate fitness subscription solution tailored for employers, as well as personalized, data-driven fitness experiences for users. This approach supports individuals in achieving their fitness goals, whether related to muscle gain, performance, or rehabilitation. EGYM's commitment to member success is reflected in its belief that the success of gym operators is intrinsically linked to the progress of their members towards improved physical and mental wellness.

Refurbed GmbH is an online marketplace based in Vienna, Austria, specializing in the sale of refurbished electronic goods. Founded in 2017, the company offers a wide range of products, including smartphones, laptops, tablets, TVs, smartwatches, headphones, consoles, cameras, and kitchen appliances. Refurbed distinguishes itself by providing refurbished devices that are renewed through a meticulous 40-step process, ensuring they look and function like new while being offered at prices up to 40% lower than new items. Additionally, all products come with a minimum 12-month guarantee, making them a more environmentally friendly and cost-effective choice for consumers.

Expertlead is an HR tech company that specializes in the recruitment and technical qualification of IT professionals. The company leverages a unique blend of technology and community expertise to identify and evaluate suitable candidates. Its innovative peer-to-peer interview process assesses the technical skills of IT applicants, utilizing the collective knowledge of a global tech community. This approach ensures rigorous quality checks across various programming languages. Additionally, Expertlead provides a comprehensive recruiting software solution, facilitating efficient access to a network of highly qualified freelancers in software development, data science, project management, solution architecture, and UX/UI design. By connecting clients with vetted digital and technology talent, Expertlead aims to streamline the recruitment process for complex projects.

Motus GI is a medical technology company that focuses on improving outcomes in endoscopy and enhancing patient experiences in the diagnosis and management of gastrointestinal conditions. Based in Fort Lauderdale, Florida, and with operations in Israel, the company has developed the Pure-Vu System, a medical device designed to assist in the cleaning of poorly prepared colons during colonoscopy procedures. This device aims to facilitate better visualization and improve the overall effectiveness of the colonoscopy, contributing to the early detection and prevention of colorectal cancer and other gastrointestinal diseases. The Pure-Vu System has received clearance from the U.S. Food and Drug Administration and is also CE marked for use in the European Economic Area.

Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden, dedicated to developing and commercializing treatments for patients with significant unmet medical needs, particularly in niche indications. The company is primarily focused on its product candidate, Nefecon, which features a patented formulation designed to deliver budesonide directly to the target area, aiming to treat IgA nephropathy, an inflammatory renal disease. Calliditas is currently conducting a global Phase 3 clinical trial for Nefecon and plans to bring the medication to market in the United States. Additionally, the company is exploring novel treatments for orphan indications, with a particular emphasis on renal and hepatic diseases.

Grover is an online platform that allows consumers to rent a wide variety of tech products through monthly subscriptions. With a catalog of over 3,000 items, Grover offers access to smartphones, laptops, VR gear, wearables, and smart home appliances. The company's business model emphasizes sustainability by refurbishing and re-circulating returned products, thereby extending their lifespan and minimizing electronic waste. By enabling users to rent instead of purchase, Grover provides an affordable alternative for accessing consumer electronics. The company operates in multiple markets, including the United States, Germany, Austria, the Netherlands, and Spain.

PlusDental is a rapidly growing digital health startup based in Berlin, specializing in digital orthodontics. The company focuses on treating cosmetic cases of malocclusion, primarily through the use of clear aligners, which provide a modern alternative to traditional braces. By leveraging advanced 3D technology and collaborating with experienced orthodontists and dentists, PlusDental offers innovative solutions for correcting dental misalignments. The company's mission is to make orthodontic treatments more convenient and affordable, thereby expanding access to this effective and versatile method of teeth straightening. Through its efforts, PlusDental aims to revolutionize aesthetic orthodontics in Europe and help more patients achieve brighter smiles.

Recharge is a B2C prepaid payments platform operating multiple digital storefronts including Recharge.com and Startselect.com. With its mission to 'Make Prepaid Easy,' the company distributes over 16,000 different types of digital vouchers and prepaid products, for large prepaid categories such as e-gift, shopping, and gaming cards, prepaid money cards, and international mobile and cross-border top ups. Through providing consumers with simple access to these Prepaid Payment Products they are driving a new era of accessibility to financial empowerment, giving consumers greater spending control and flexibility on their terms. Founded in 2010, today they operate in over 180 markets whilst headquartered in Amsterdam. The company is backed by Prime Ventures, Smartfin, Committed Capital and BlackRock raising ~$75M in Series A & B rounds to date.

TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading drug candidates, NOX-A12 and NOX-E36, derived from a novel class of therapeutics known as Spiegelmers. These compounds are designed to improve the effectiveness of existing cancer therapies by offering specific advantages over traditional drug classes. TME Pharma maintains a strategic alliance with Pfizer, Inc., underscoring its commitment to advancing innovative treatment options in oncology. The company is headquartered in Berlin, Germany.

Numa Group is a Berlin-based company recognized as the leading European operator of a fully digitized hospitality platform. It provides modern travelers with innovative accommodation options that serve as an alternative to boutique hotels and managed short-stay apartments. Numa's offerings include features such as electronic check-in, kitchen facilities, workstations, professional housekeeping, and locally curated recommendations, aiming to deliver an authentic experience for guests. The company employs proprietary technology to automate many operational processes, enhancing cost efficiency and revenue for property owners and investors. Numa currently manages over 8,000 units across major European cities, including Berlin, London, Paris, and Rome, positioning itself as a reliable partner in the hospitality sector.

Essor focuses on business tasks such as acquisitions, investments, sourcing, and marketing, allowing third-party seller brands from diverse marketplaces to reach global scale growth. Essor’s brand portfolio today includes a broad range of rapidly growing health & wellness and lifestyle brands like Boka, ZitSticka, Puracy, OTOTO Design, FreshCap, Iron Flask, Fullstar, numnum, Key Nutrients, and Viking Revolution that are sold on Amazon, Direct to Consumer channels, and through national retailers like Target, CVS, and Walmart.

Quali is a provider of automation and orchestration software aimed at enhancing the DevOps lifecycle and productivity for enterprise engineering teams. Its SaaS-based platform utilizes cloud sandboxes, which serve as personal replicas of production environments, to facilitate the automation of DevOps processes. This enables comprehensive product lifecycle testing, management, and optimization. By streamlining these operations, Quali helps enterprises and service providers improve developer productivity, enhance cloud governance, and achieve greater efficiency across engineering, sales, and security organizations, all while reducing operational costs.

Kandou Bus SA is a company that specializes in designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Switzerland, Kandou has developed a unique approach to serial link design that enhances data transfer speeds while minimizing power consumption. Their technology is utilized across various electronic devices, including DRAM, graphics cards, server backplanes, mobile devices, and game consoles, effectively increasing data throughput and extending battery life. Additionally, Kandou's solutions address the growing demand for bandwidth in applications such as routers and FPGAs, where they improve performance while reducing pin counts and overall energy usage. The company operates with a team of skilled scientists and engineers across Switzerland, the UK, and the US, focusing on advancing the capabilities of serial links to support innovative electronic designs.

Syte is a technology company based in Tel Aviv that specializes in developing a product discovery platform aimed at enhancing online shopping experiences. Utilizing advanced visual AI technology, Syte transforms the way consumers search and shop for fashion by enabling features such as camera search, augmented site search, and personalized recommendations. Their solutions allow users to upload images of products they find inspiring, which the platform then matches with visually similar items available on a retailer’s site. Additionally, Syte offers smart merchandising tools to help retailers improve site navigation and product discovery, ultimately driving sales and fostering brand loyalty. Founded in 2014 by Helge Voss, Idan Pinto, Lihi Pinto Fryman, and Ofer Fryman, the company has successfully raised $71 million from various investors to further its mission of revolutionizing the online shopping landscape.

Neuromod Devices Limited is a Dublin-based medical device company founded in 2010, focusing on the research and development of neuromodulation treatments for chronic tinnitus, a condition affecting approximately 10% of adults. The company has developed a patented bi-modal neuromodulation technology, exemplified by its product, the mutebutton. This device aims to promote positive therapeutic changes in the nervous system, offering a targeted approach to alleviate the suffering of patients living with chronic tinnitus. Neuromod is dedicated to providing innovative treatments that empower patients to manage their conditions while integrating seamlessly into their modern lifestyles.

Abivax is a clinical-stage biotechnology company based in France that develops therapeutics aimed at harnessing the body's natural immune response to treat autoimmune diseases, viral infections, and cancer. The company is currently evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Abivax focuses on addressing significant unmet medical needs in chronic inflammatory diseases, particularly inflammatory bowel diseases, which include ulcerative colitis and Crohn's disease. Through its innovative drug development platforms, Abivax aims to provide novel and effective treatment options for patients suffering from these conditions.

Bnext is a fintech platform based in Madrid, Spain, that functions as a supermarket for financial products. It offers users the ability to create a current account quickly, providing nearly all the functionalities of a traditional bank without the need to engage with one. Users can consolidate their financial information by linking external accounts on the platform. The core innovation of Bnext is its Marketplace, where users can explore a diverse range of financial products from various fintechs and banks, all selected to meet their specific needs. This platform allows users to purchase and manage these products seamlessly within the app, without incurring excessive fees. Rather than focusing on selling numerous products, Bnext collaborates with fintechs to present the best available offers, encompassing services such as real estate investments, mutual funds, loans, and crowdfunding. By progressively integrating leading market products, Bnext aims to redefine banking by becoming a comprehensive financial service provider without the limitations of a traditional bank.

ViCentra B.V., based in Utrecht, the Netherlands, specializes in the development of medical devices, particularly for diabetes management. The company focuses on creating user-friendly and aesthetically pleasing products that aim to enhance the overall experience for individuals managing their health. ViCentra emphasizes the importance of excellent customer experiences and approaches product design with the belief that simplicity and effectiveness lead to better health outcomes. In addition to its operations in the Netherlands, ViCentra also has a presence in the UK, where it continues to innovate in the field of medical devices through dedicated research and development efforts.

Zerto Ltd. specializes in disaster recovery and business continuity software for virtualized data centers and cloud environments. Founded in 2009 and headquartered in Boston, Massachusetts, the company offers the Zerto Cloud Continuity Platform, which includes its flagship product, Zerto Virtual Replication. This software enables organizations to protect, recover, and migrate applications across public, private, and hybrid clouds. Zerto's solutions are designed to simplify the complexities associated with modernization and cloud adoption, making it easier for enterprises to maintain continuous operations. The company's products are utilized in various applications, including Oracle, SAP, and SQL server replication and recovery, serving industries such as healthcare, legal, and finance. Zerto operates globally, with offices in locations including Israel, Japan, the United Kingdom, India, Canada, Mexico, and Brazil.

Smava is a prominent credit comparison portal in Germany that facilitates connections between private borrowers and a diverse range of banks and private investors through its online platform. The company specializes in brokering loans, offering customers a variety of options in terms of amounts and interest rates, which allows for tailored loan solutions. In recent years, Smava has experienced significant growth, with its brokered loan volume increasing from approximately EUR 2 billion in 2018 to around EUR 2.7 billion in 2019, and further rising to about EUR 900 million in the first quarter of 2020 compared to the same period the previous year. To date, Smava has successfully brokered over EUR 8 billion in loans, underscoring its role as a key player in the online lending market.

Scandit AG is a technology company specializing in barcode scanning software solutions and mobile computer vision. Founded in 2009 and headquartered in Zurich, Switzerland, with additional offices in the United States and Europe, Scandit develops applications that enable high-performance scanning on various smart devices, including smartphones, tablets, and wearables. Its offerings include the Barcode Scanner SDK, which transforms devices into enterprise-grade scanning tools, and the MatrixScan feature that enhances recognition processes for retail and logistics. Scandit's solutions are utilized across multiple industries, such as retail, healthcare, and manufacturing, to support applications like mobile shopping, inventory management, and asset tracking. The company's technology also incorporates augmented reality capabilities, providing real-time information overlays to improve user experience. Scandit aims to enhance operational efficiency and customer satisfaction for organizations, serving a diverse clientele that includes well-known brands.

Inotrem S.A. is a biotechnology company that specializes in immunotherapy aimed at managing acute and chronic inflammatory syndromes. The company focuses on the TREM-1 pathway to regulate excessive inflammatory responses, utilizing its proprietary technology platform. Inotrem has developed a first-in-class TREM-1 inhibitor known as nangibotide (LR12), which shows promise in treating conditions such as septic shock and myocardial infarction. In addition to its acute inflammatory initiatives, Inotrem is also advancing a program targeting chronic inflammatory diseases, thereby expanding its therapeutic scope. Through its innovative approach, Inotrem aims to enhance treatment options for critical care patients facing a variety of inflammatory challenges.

Funnel is a marketing analytics and reporting software that aims to streamline data collection for online advertisers and e-commerce companies. Founded in 2014 by Fredrik Skantze and Per Made, the company provides a platform that integrates with over 400 marketing and advertising sources. This allows businesses to automatically collect and structure advertising performance data, facilitating better decision-making regarding advertising spend and business growth. Funnel enables users to feed data into various tools, including Business Intelligence platforms, Data Warehouses, and visualization tools like Google Data Studio and Google Analytics. The company serves a diverse clientele, including e-commerce businesses, media agencies, brands, B2B enterprises, mobile applications, and gaming companies. Funnel operates from its headquarters in Stockholm, with an additional office in Boston.

GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on developing gene therapy treatments for retinal degenerative diseases and neurodegenerative conditions affecting the central nervous system. Utilizing its core technology platforms—Mitochondrial Targeting Sequence and Optogenetics—the company aims to preserve and restore vision in patients with severe retinal disorders. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III trials for treating Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. In addition to these, GenSight is advancing several products in preclinical stages targeting various ophthalmic and neurodegenerative diseases. Founded in 2012, the company is dedicated to innovative approaches that aim to prevent vision loss and improve the quality of life for affected patients.

Voi, Inc. is a behavioral healthcare technology company that focuses on using artificial intelligence to address suicide prevention and other behavioral health challenges. The company offers two primary products: Voi Detect, an AI-driven solution designed to identify near-term suicide risk through a digital interface, and Voi Reach, a mobile application that supports at-risk individuals by connecting them with a network of family, friends, and therapists. These solutions cater to service members, patients, students, and veterans, aiming to assist those at risk and their support systems. Founded in 2013 and initially known as First Opinion, Inc., Voi is headquartered in San Francisco, California.

Typelane AB is a Stockholm-based company that develops tools aimed at enhancing the employee experience throughout the entire employment cycle, from onboarding to offboarding. Founded in 2016, Typelane offers products such as Journeys, which facilitate the onboarding and offboarding processes, and Conversations, a chat-based tool that fosters communication between employees and management. The platform incorporates artificial intelligence to provide real-time analytics, actionable insights, and notifications, all designed to simplify and personalize the traditionally complex and manual workflows. By focusing on intuitive design and smart automation, Typelane transforms these essential HR processes into engaging experiences for employees, ensuring a seamless transition at every stage of their employment.

MDxHealth is a molecular diagnostics company focused on developing and commercializing advanced epigenetic tests to assist in the detection and treatment of cancer. The company's product portfolio includes ConfirmMDx, a prostate cancer test aimed at addressing false-negative biopsy concerns; SelectMDx, which guides repeat biopsies for prostate cancer; AssureMDx, a noninvasive liquid biopsy test for bladder cancer; and PredictMDx for Glioblastoma, a tissue methylation test that aids in treatment decisions for brain cancer. Established in 2003 and headquartered in Irvine, California, with additional offices in Belgium and the Netherlands, MDxHealth leverages proprietary genomic and epigenetic technologies to provide actionable diagnostic information. The company's revenue is generated through clinical laboratory services and out-licensing of its patented DNA methylation platform and biomarkers, serving markets primarily in the United States and Europe.

Neuromod Devices Limited is a Dublin-based medical device company founded in 2010, focusing on the research and development of neuromodulation treatments for chronic tinnitus, a condition affecting approximately 10% of adults. The company has developed a patented bi-modal neuromodulation technology, exemplified by its product, the mutebutton. This device aims to promote positive therapeutic changes in the nervous system, offering a targeted approach to alleviate the suffering of patients living with chronic tinnitus. Neuromod is dedicated to providing innovative treatments that empower patients to manage their conditions while integrating seamlessly into their modern lifestyles.

Kandou Bus SA is a company that specializes in designing high-speed, energy-efficient chip-to-chip links and associated technologies. Founded in 2011 and based in Lausanne, Switzerland, Kandou has developed a unique approach to serial link design that enhances data transfer speeds while minimizing power consumption. Their technology is utilized across various electronic devices, including DRAM, graphics cards, server backplanes, mobile devices, and game consoles, effectively increasing data throughput and extending battery life. Additionally, Kandou's solutions address the growing demand for bandwidth in applications such as routers and FPGAs, where they improve performance while reducing pin counts and overall energy usage. The company operates with a team of skilled scientists and engineers across Switzerland, the UK, and the US, focusing on advancing the capabilities of serial links to support innovative electronic designs.

BUX is a fintech company founded in 2014 and based in Amsterdam, Noord-Holland. It focuses on making investing accessible and affordable through its mobile applications, which enable commission-free trading in stocks and exchange-traded funds (ETFs). The platform is designed to lower the barriers to entry for both novice and seasoned investors, allowing them to engage with the financial markets intuitively. Additionally, BUX offers the ability to invest in real cryptocurrencies, further broadening the investment opportunities available to its clients.

Gett, Inc. is a technology platform specializing in on-demand corporate ground transportation management. Founded in 2010 and headquartered in London, the company offers a cloud-based software solution that connects businesses with a wide range of transportation providers, including corporate fleets, ride-hailing services, taxis, and limousines. This integrated platform streamlines the management of transportation expenses, enhancing the overall employee experience from booking to invoicing and analytics. Gett operates in multiple countries, including the United Kingdom, the United States, and Russia, and has established partnerships, notably with The Volkswagen Group. With a workforce of over 800 employees, Gett aims to set a new standard in corporate ground transportation, much like the impact of leading communication platforms in their respective fields.

Butternut Box is a UK-based startup founded by friends Kev and Dave, specializing in fresh, human-grade dog food made from real ingredients. The company emphasizes the quality and nutritional value of its meals, providing a personalized approach to dog nutrition. By collecting information on each dog's age, size, allergies, and dietary needs, Butternut Box tailors meal plans to meet the specific requirements of individual pets. This customer-centric model not only aims to enhance the health and well-being of dogs but also simplifies the feeding process for pet owners by delivering customized, homemade meals directly to their doors.

Nicox is a biopharmaceutical company based in Sophia Antipolis, France, focused on developing and commercializing nitric oxide (NO)-donating drugs for various health conditions, particularly inflammation and cardio-metabolic diseases. The company's primary product candidates include Naproxcinod, which is in Phase III trials for osteoarthritis, and NCX 6560, an NO-donating compound in Phase I trials targeting cardiovascular diseases. Additionally, Nicox's portfolio features several drugs in clinical development, such as PF-03187207 for glaucoma, TPI 1020 for respiratory disorders, and NCX 1510 for allergic rhinitis, all in Phase II trials. The company's pipeline also includes NCX 1047, aimed at treating skin disorders, and various NO-donors for conditions like diabetic retinopathy and hypertension. Collaborations with organizations such as Orexo AB, Pfizer Inc., and Merck & Co. further enhance its research and development capabilities. Founded in 1996, Nicox is dedicated to advancing innovative therapeutic solutions to improve patient outcomes in ophthalmology and beyond.

SuperSonic Imagine SA is a medical technology company that specializes in developing and manufacturing advanced ultrasound imaging systems. Founded in 2005 and headquartered in Aix-en-Provence, France, the company is renowned for its Aixplorer system, which provides high-definition imaging and is particularly effective in diagnosing and monitoring breast, prostate, and thyroid cancers, as well as liver diseases. The Aixplorer system incorporates ShearWave technology, enabling quantitative elastography that measures tissue elasticity. SuperSonic Imagine operates primarily in markets such as China, the United States, and various European countries, distributing its products through a network of offices and distributors. As a subsidiary of Hologic Hub Ltd, the company continues to innovate in the field of medical imaging, enhancing the capabilities of healthcare professionals.

Quali is a provider of automation and orchestration software aimed at enhancing the DevOps lifecycle and productivity for enterprise engineering teams. Its SaaS-based platform utilizes cloud sandboxes, which serve as personal replicas of production environments, to facilitate the automation of DevOps processes. This enables comprehensive product lifecycle testing, management, and optimization. By streamlining these operations, Quali helps enterprises and service providers improve developer productivity, enhance cloud governance, and achieve greater efficiency across engineering, sales, and security organizations, all while reducing operational costs.

Affluent Medical is a medical device company based in Paris, France, specializing in the design, development, manufacturing, and marketing of implantable prostheses. Founded in 2011, the company focuses on next-generation minimally invasive devices aimed at treating severe medical conditions. Its product lineup includes the Kardiozis prosthesis, which addresses abdominal aortic aneurysms, and the Kalios and Epygon implants, designed for mitral valve repair and replacement. Kalios addresses post-operative leakage and recurrent mitral insufficiency without the need for additional surgeries, while Epygon is notable for being a developing transcatheter valve that restores natural blood flow. Additionally, Affluent Medical has created Artus, the first electronically activatable artificial sphincter for the treatment of severe urinary incontinence in both men and women.

Planday is a cloud-based workforce management platform that aims to streamline communication between employees and businesses. It provides tools for creating and managing optimal work schedules by considering various factors such as staffing requirements, budget constraints, employee availability, and workforce regulations. The platform is designed to reduce staff costs by 5%, cut administration time by 75%, and enhance employee satisfaction by 20%. Planday serves a diverse range of industries, including restaurants, hotels, retail, call centers, and fitness clubs, enabling organizations to facilitate collaborative and real-time interactions among hourly employees and their workplaces.

Kiadis Pharma N.V. is a clinical-stage biopharmaceutical company based in Amsterdam, the Netherlands, specializing in the development of cell-based immunotherapy products for blood cancers and inherited blood disorders. The company is currently advancing its product pipeline, which includes K-NK002, an adjunctive immunotherapeutic in Phase II trials for blood cancer patients undergoing haploidentical hematopoietic stem cell transplants, and K-NK003, which is in Phase I/II trials for patients with acute myeloid leukemia who are relapsed or refractory. Additionally, Kiadis Pharma is developing K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company is engaged in collaborative efforts with multiple institutions to explore innovative treatments, including a combination of a monoclonal antibody and natural killer cells for COVID-19. Established in 1997, Kiadis Pharma addresses critical unmet medical needs in oncology through its innovative therapeutic approaches.

Abivax is a clinical-stage biotechnology company based in France that develops therapeutics aimed at harnessing the body's natural immune response to treat autoimmune diseases, viral infections, and cancer. The company is currently evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Abivax focuses on addressing significant unmet medical needs in chronic inflammatory diseases, particularly inflammatory bowel diseases, which include ulcerative colitis and Crohn's disease. Through its innovative drug development platforms, Abivax aims to provide novel and effective treatment options for patients suffering from these conditions.

Signal AI is a technology company founded in 2013 and headquartered in London, England, that specializes in media intelligence and augmented decision-making. The company has developed a platform that utilizes advanced machine learning to analyze text and uncover market intelligence, providing businesses with valuable insights into digital, print, and broadcast media, as well as regulatory data. By aggregating and analyzing this information, Signal AI empowers leaders to track their competitive landscape, monitor changes in regulation, and manage their reputations effectively. This capability enables organizations to identify risks and opportunities, facilitating smarter and faster business decisions.

Signal AI is a technology company founded in 2013 and headquartered in London, England, that specializes in media intelligence and augmented decision-making. The company has developed a platform that utilizes advanced machine learning to analyze text and uncover market intelligence, providing businesses with valuable insights into digital, print, and broadcast media, as well as regulatory data. By aggregating and analyzing this information, Signal AI empowers leaders to track their competitive landscape, monitor changes in regulation, and manage their reputations effectively. This capability enables organizations to identify risks and opportunities, facilitating smarter and faster business decisions.

BioCatch is a pioneering company specializing in behavioral biometrics, which focuses on analyzing the digital behavior of online users to enhance fraud detection and prevention. By leveraging advanced cognitive science and machine learning, BioCatch provides insights that help financial institutions identify potential risks associated with user interactions while maintaining privacy. The company's technology is designed to combat increasingly sophisticated fraud tactics, including social engineering scams, and to streamline the digital banking experience from account creation to login and beyond. With over a decade of experience and a robust portfolio of patents, BioCatch is committed to driving innovation in the field of digital security, enabling clients to effectively combat fraud while fostering a trusted online environment.

Profile Pensions is a UK-based provider of pension advisory services aimed at helping individuals understand and improve their retirement savings. The company offers impartial and expert advice, making pension investment guidance accessible to a wide range of clients, regardless of their financial knowledge or status. Their services include recommending investment funds, tracing lost pensions, and providing a pension calculator, all designed to empower clients to enhance their pension wealth. By focusing on affordability and accessibility, Profile Pensions aims to assist individuals in taking proactive steps toward securing a better financial future in retirement.

Currencycloud is a global payments platform that simplifies cross-border transactions and foreign exchange automation for businesses. It provides developers with API building blocks to create tailored payment solutions, allowing companies to integrate payment infrastructure into their products and services seamlessly. The platform offers automated end-to-end processes for sending and receiving payments, as well as services for currency collection and conversion. By handling the complexities and regulatory requirements associated with international payments, Currencycloud enables clients to adopt digital wallets and embed financial services into their operations, regardless of their industry.

Mereo Biopharma, based in London and founded in 2015, specializes in developing and commercializing innovative therapeutics for rare diseases and cancer. The company addresses the challenges faced by large pharmaceutical firms in resource allocation for drug development, particularly for candidates beyond Phase 2 trials. Mereo has acquired a mid-late stage portfolio of three well-characterized products from Novartis Pharmaceuticals, each backed by robust pre-clinical and proof-of-concept clinical data. The company focuses on transforming patient outcomes through its pipeline of drugs targeting significant unmet medical needs. Mereo leverages its team's expertise in selecting and advancing product opportunities and collaborates with ICON, a leading global contract research organization, to enhance its operational efficiency. Mereo aims to progress its products through critical development milestones before considering partnerships or commercialization, particularly in orphan disease indications.

Kiadis Pharma N.V. is a clinical-stage biopharmaceutical company based in Amsterdam, the Netherlands, specializing in the development of cell-based immunotherapy products for blood cancers and inherited blood disorders. The company is currently advancing its product pipeline, which includes K-NK002, an adjunctive immunotherapeutic in Phase II trials for blood cancer patients undergoing haploidentical hematopoietic stem cell transplants, and K-NK003, which is in Phase I/II trials for patients with acute myeloid leukemia who are relapsed or refractory. Additionally, Kiadis Pharma is developing K-NK00X, a preclinical NK-cell therapy candidate aimed at treating various solid tumors. The company is engaged in collaborative efforts with multiple institutions to explore innovative treatments, including a combination of a monoclonal antibody and natural killer cells for COVID-19. Established in 1997, Kiadis Pharma addresses critical unmet medical needs in oncology through its innovative therapeutic approaches.

Puls is a venture-funded startup based in San Francisco, California, that operates a nationwide platform connecting customers with service providers for a range of home services. Founded in 2015, the company specializes in handyman services, appliance repair, TV mounting, and disinfection. Its offerings include furniture assembly, wall hanging, drywall repair, interior painting, and installation of various appliances and devices. Additionally, Puls provides same-day repair services for tech devices, Wi-Fi configuration, garage door installation, and security system setup. By facilitating convenient access to local technicians, Puls aims to meet the diverse needs of homeowners and enhance their service experience.

Signal AI is a technology company founded in 2013 and headquartered in London, England, that specializes in media intelligence and augmented decision-making. The company has developed a platform that utilizes advanced machine learning to analyze text and uncover market intelligence, providing businesses with valuable insights into digital, print, and broadcast media, as well as regulatory data. By aggregating and analyzing this information, Signal AI empowers leaders to track their competitive landscape, monitor changes in regulation, and manage their reputations effectively. This capability enables organizations to identify risks and opportunities, facilitating smarter and faster business decisions.

CellNovo is a medical device company focused on diabetes management. The company develops and markets a comprehensive system that includes a cordless micro-pump, an integrated monitoring device, and a cellular handset with a touch screen and embedded blood glucose meter. This innovative system facilitates the automatic transmission of data, allowing for real-time monitoring of patients' conditions through mobile connectivity. By creating an interconnected diabetes management solution, CellNovo aims to enhance the quality of care for individuals living with diabetes.

TME Pharma is a clinical-stage biopharmaceutical company focused on enhancing cancer treatment by targeting the tumor microenvironment. The company develops biostable aptamers and mirror image nucleic acids, with its leading drug candidates, NOX-A12 and NOX-E36, derived from a novel class of therapeutics known as Spiegelmers. These compounds are designed to improve the effectiveness of existing cancer therapies by offering specific advantages over traditional drug classes. TME Pharma maintains a strategic alliance with Pfizer, Inc., underscoring its commitment to advancing innovative treatment options in oncology. The company is headquartered in Berlin, Germany.

ROLI is a music technology company that specializes in creating innovative hardware and software solutions for music learning and creation. The firm develops a modular music creation system that features a three-dimensional pressure-sensing digital keyboard, designed to enhance musical expression by responding to variations in pressure. ROLI's team, composed of musicians, programmers, teachers, anthropologists, engineers, and artists, is dedicated to redefining how individuals engage with music through their products, which include a range of music-making devices, software, sounds, and accessories. By focusing on the intersection of technology and music, ROLI aims to make music more accessible and expressive for users of all skill levels.

Proveca Ltd. is a pharmaceutical company based in Daresbury, United Kingdom, that specializes in identifying, researching, and licensing off-patent medicines aimed at addressing unmet healthcare needs in the pediatric market. Founded in 2010, Proveca focuses on developing formulations and clinical data necessary to obtain Pediatric Use Marketing Authorisation (PUMA) for its products, which include treatments for conditions such as sialorrhoea, epilepsy, heart failure, and acute pain. The company seeks to secure market protection and exclusivity for its medicines by pursuing PUMA and, where applicable, Orphan Drug status. By doing so, Proveca aims to ensure that its licensed medicines are commercially viable and beneficial for children, either through direct commercialization or by selling the licenses to larger pharmaceutical firms.

SoundCloud is a social sound platform launched in 2008 by Alexander Ljung and Eric Wahlforss, designed to enable users to create, share, and discover a vast array of audio content. It serves as an open platform that connects sound creators directly with their audiences, allowing artists to upload, record, and promote their music while receiving valuable feedback and analytics from the community. The platform supports both private sharing among friends and public distribution to blogs, websites, and social networks, facilitating the promotion and discovery of diverse musical works. Through its innovative features, SoundCloud fosters a vibrant community for musicians and listeners alike.

CrossLend GmbH operates an online lending platform that facilitates digital credit mediation and financing across Europe. Founded in 2014 and headquartered in Berlin, Germany, the company collaborates with partner banks to provide cross-border credit mediation. Its platform connects private and institutional investors from low-interest rate countries with borrowers in high-interest rate regions, enabling efficient loan transactions. CrossLend offers a variety of financial products, including consumer loans, development loans, mortgages, and SME loans. The company also focuses on digital infrastructure and standardization, allowing for the securitization of loans into bonds for investment, thereby providing attractive risk-return profiles for investors and favorable interest rates for borrowers.

Teridion is a cloud-based global connectivity platform that offers wide-area network services to enhance connectivity and speed for enterprises and SaaS companies. With a network comprising over 500 points of presence worldwide and partnerships with more than 25 public clouds, Teridion ensures stable, high-performance connectivity, including access within mainland China. Its WAN as a service solution is designed for easy scalability and setup, requiring no additional hardware or software. By utilizing proprietary algorithms, Teridion directs traffic to optimal entry points based on bandwidth, latency, and geography, creating a real-time congestion map of the internet. This approach allows Teridion to address middle-mile issues effectively, providing up to 20 times more throughput compared to traditional public internet connections.

BONESUPPORT AB is a medical technology company based in Lund, Sweden, specializing in the development of injectable bioceramic bone graft substitutes aimed at treating fractures and bone voids resulting from trauma, infection, disease, or surgery. Founded in 1999, the company offers a range of products, including CERAMENT BONE VOID FILLER, CERAMENT G, and CERAMENT V. These products are designed to address various medical conditions such as chronic osteomyelitis and infected diabetic foot ulcers. CERAMENT G and CERAMENT V are antibiotic-eluting bone graft substitutes that enhance bone healing, utilizing gentamicin and vancomycin, respectively. BONESUPPORT operates additional locations in Frankfurt, Zurich, London, Boston, and Haryana, India, and is committed to improving the quality of life for patients with bone disorders through innovative biomaterial solutions.

Electro Power Systems operates in the sustainable energy sector, focusing on hybrid-storage solutions and microgrids that convert intermittent renewable energy into a reliable power source. Headquartered in Paris, with research, development, and manufacturing facilities in Italy, the company has developed innovative hybrid energy storage technologies, supported by 125 patents and over a decade of research and development. These solutions are designed to stabilize electrical grids with high levels of renewable energy integration in developed countries and provide cost-effective off-grid power in emerging economies without relying on subsidies. Electro Power Systems has successfully implemented and is commissioning 36 large-scale projects, including off-grid hybrid systems and grid support systems, totaling over 47 MWh of capacity across 21 countries, serving more than 165,000 customers daily.

Pixium Vision SA is a bioelectronics company based in Paris, France, focused on developing innovative retinal implant systems to restore vision for individuals who have lost sight due to degeneration of photoreceptor cells in the retina. Established in 2011, Pixium Vision's primary product is the PRIMA System, a bionic vision system designed to improve visual perception and promote greater independence among users. The company is advancing several devices, including the IRIS1, currently undergoing clinical trials, and the next-generation IRIS2, which aims to enhance visual acuity. Additionally, Pixium is working on the IRIS3, a sub-retinal implant that promises further improvements in vision. The company collaborates with prestigious institutions such as Stanford University, Moorfields Eye Hospital, and the Institut de la Vision, utilizing cutting-edge research in neural processing and micro-electronics to drive its innovations. Pixium Vision is supported by a consortium of prominent European venture capital firms.

Since 2012 Reduxio has redefined data management and data protection, and the company has evolved its mission to deliver the first microservices-based storage and data platform for stateful applications. Reduxio’s cloud data platform for Kubernetes pairs high performance software-defined container-native storage and data management with data mobility to enable customers to build a single data cloud for their applications across all their infrastructure, anywhere. Reduxio is backed by Intel Capital, C5 Capital Cloud Partners and Jerusalem Venture Partners (JVP).

Searchmetrics GmbH is a leading provider of search analytics software and consulting solutions, primarily based in Berlin, Germany, with additional offices in New York, San Mateo, London, and Varaždin. Founded in 2007, the company specializes in helping businesses enhance their search engine optimization (SEO) performance through its comprehensive SaaS platform, the Searchmetrics Suite. This suite includes modules such as Research Cloud, Content Experience, Search Experience, and Site Experience, which collectively provide tools for SEO professionals and content marketers to optimize their search and content strategies. Searchmetrics also offers a variety of services, including SEO consulting and market research insights derived from search data. By leveraging advanced analytics, Searchmetrics helps organizations like AXA, Lowe’s, and McKinsey & Company navigate the complexities of digital marketing, gain competitive advantages, and drive revenue growth through improved search performance.

Zooz is a technology company founded in 2010 that specializes in a payments platform aimed at enhancing merchants' payment performance. The platform offers a comprehensive payment application that integrates various acquirers, e-wallets, alternative payment methods, and fraud management services. By streamlining the transaction process, Zooz enables businesses to optimize their payment operations within a complex ecosystem. In July 2018, Zooz was acquired by PayU, further expanding its reach and capabilities in the payments industry.

Savedo GmbH is an online marketplace based in Berlin, Germany, founded in 2014, that facilitates investment in fixed-term deposits across the European Union. The platform allows users in Germany, Austria, and the Netherlands to access better interest rates on their savings without the need to travel to different countries. By partnering with various banks, Savedo provides essential services such as customer support and standardized account documentation, streamlining the investment process for its clients. As of August 2017, Savedo operates as a subsidiary of Deposit Solutions GmbH and is staffed by a team of experienced finance professionals and online specialists dedicated to enhancing retail investment opportunities in Europe.

Marley Spoon Inc., operating under the name Marley Spoon, is a meal kit service established in 2014 and headquartered in New York, New York. The company specializes in delivering weekly meal kits that include pre-portioned ingredients and recipes directly to customers' doors, enabling them to prepare home-cooked meals. As a subsidiary of Marley Spoon AG, the company focuses on providing a convenient culinary experience, allowing customers to enjoy a variety of dishes without the hassle of grocery shopping.

Widespace is an advertising company specializing in mobile advertising, established in 2007 by Patrik Fagerlund and Henric Ehrenblad. The company operates a mobile ad network that assists businesses in monetizing their mobile applications. Widespace has developed a technology platform designed to facilitate branding campaigns on mobile devices. This platform includes a comprehensive programmatic advertising solution and a marketplace that offers various ad formats and targeting options. By focusing on brand safety and scalability, Widespace enables advertisers to enhance interest and awareness while improving operational efficiency.

Lifeward is a medical device company based in Marlborough, Massachusetts, specializing in innovative solutions for individuals with lower limb disabilities. The company develops, manufactures, and markets advanced walking systems, notably the ReWalk Rehabilitation System and the ReWalk Personal System. The ReWalk Rehabilitation System is designed for use in rehabilitation centers, enabling users to walk, stand, sit, and navigate stairs. In contrast, the ReWalk Personal System is intended for everyday use, allowing individuals to engage in activities at home, work, and various outdoor environments. This system supports standing, sitting, and turning, while also facilitating stair climbing and descending. Lifeward's mission is to enhance the quality of life for those with spinal cord injuries by providing robotic technologies that offer significant functional and health benefits across different settings, including clinical environments and everyday life. The company operates primarily in the United States and Europe, with additional sales in Asia, the Middle East, and South America.

ChannelSight Ltd. is a company based in Blackrock, Ireland, specializing in channel optimization solutions for brands and their trade partners. Founded in 2013, it offers a digital "Buy Now" service that facilitates e-commerce sales by helping consumers find partner retailers to purchase products. The company provides a range of solutions, including product and support pages, email campaigns, mobile and desktop applications, and various advertising formats. Its technology enhances the customer journey by offering tools like "Where To Buy" functionality, eTail monitoring, and offline locators. ChannelSight serves multiple sectors, including video games, fashion, luxury goods, and consumer electronics, helping clients improve their online sales strategies and optimize digital channels. With operations worldwide, ChannelSight aims to drive sales and conversions by providing insightful metrics and a seamless shopping experience.

CropX is an ag-analytics and IoT company that develops AI-driven, cloud-based software solutions aimed at enhancing agricultural productivity. Its platform integrates data from proprietary and third-party sources, enabling farmers to improve crop yields by up to 15% while significantly reducing water, pesticide, and fertilizer usage by up to 50% and 20%, respectively. The software combines advanced soil sensor technology with comprehensive agricultural information, facilitating efficient irrigation management and operational automation. Trusted by farmers globally, CropX has been deployed on over 5,000 farms across 70 countries. The company fosters partnerships with key industry players, including Reinke, Syngenta, PepsiCo, and John Deere, to streamline data sharing and enhance farming practices, promoting sustainable and profitable cultivation methods.

Blackwood Seven is a media analytics platform which strives to increase the effect of company’s media spend using our predictive analytics framework built on machine learning and artificial intelligence. Using real-time modelling and advanced KPI prediction we are able to increase a company’s media ROI by up to 15-25%.

LiquidM Inc. offers a white-labeled mobile advertising management platform designed for agencies and trading desks. Founded in 2013 and based in New York, the company provides a modular, cloud-based software solution that enables users to set up and manage advertisements with tailored settings, targets, and supply partners. The platform is agnostic to third-party integrations, allowing seamless connections with data management platforms, targeting providers, and tracking solutions. By combining media, data, technology, and strategy, LiquidM enhances efficiency and control in media planning and buying, offering deeper insights that drive improved results in the mobile display media marketplace.

Rockley Photonics Limited is a London-based company founded in 2013 that specializes in silicon photonics for various applications. The company develops a comprehensive range of photonic integrated circuits, sensors, and full-stack solutions aimed at high-volume markets. Rockley's technology is designed for next-generation sensing platforms, including mobile health monitoring and machine vision, as well as for high-speed data communications. By focusing on integrated optical modules, supporting electronics, software, and AI platforms, Rockley aims to establish a strong presence in dynamic and rapidly growing sectors. The company envisions photonics becoming as ubiquitous as microelectronics, leveraging its versatile platform to address diverse market needs.

Sckipio Technologies is a semiconductor company based in Ramat Gan, Israel, that specializes in Gfast technologies aimed at providing ultra-broadband access. Founded in 2012, Sckipio focuses on delivering fiber-like broadband capabilities over existing infrastructure, specifically through next-generation G.fast-based Fiber-to-the-Distribution Point (FTTdp) architectures. The company is notable for being the first to launch Gfast modems and has made significant contributions to the Gfast standard, accounting for over 20% of its development. Sckipio's award-winning technology enables faster internet access over distances of up to 300 meters, facilitating improved connectivity for businesses and users alike.